Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-02-25 @ 5:42 PM
Study NCT ID:
NCT02308527
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2014-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
Sponsor:
University of Birmingham
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RG_11-087
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None